Search results
AbTherx Opens Antibody Discovery Technologies Research Center
Digital Journal· 19 hours ago"I'm excited to unlock the full potential of our Atlas™ Mice platform with these new automated capabilities in advanced hybridoma, single B cell screening, antibody expression ...
Anti-Ro/SSA Antibodies Have Potential to Predict ILD in SSc
Medscape· 5 days agoAnti-Ro/SSA antibodies may help predict which patients with systemic sclerosis (SSc) are at a...
Convenient at-home test identifies at-risk individuals with inadequate immunity to COVID-19
Medical Xpress· 6 days agoBy late in the pandemic, more than 96% of individuals in the U.S. ages 16 and older had COVID-19...
What causes multiple sclerosis—and why are women more at risk?
National Geographic· 5 days agoMS affects the central nervous system, the brain and spinal cord. The immune system attacks sheaths...
What causes long COVID? Case builds for rogue antibodies
Nature· 6 days agoStudy finds that antibodies from people with the debilitating condition trigger similar symptoms in...
Author Correction: Vaccination induces broadly neutralizing antibody precursors to HIV gp41 - Nature...
Nature· 5 days agoDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USATorben Schiffner, Olivia Swanson, Jeong Hyun Lee, Patrick D. Skog, Andreia M. Serra, Kimmo Rantalainen ...
Santa Ana Bio secures $168m for inflammatory disease treatments
Pharmaceutical Technology via Yahoo Finance· 5 days agoAnother candidate, SAB03, is expected to enter Phase I trials in 2025 for several severe...
Here's Why Hold Strategy Is Apt for Danaher (DHR) Stock Now
Zacks via Yahoo Finance· 5 days agoIn December 2023, Danaher acquired Abcam plc, a global supplier of protein consumables, for...
Hemogenyx Pharmaceuticals PLC Announces Operations Update
Digital Journal· 2 days agoOperations Update LONDON, UNITED KINGDOM / ACCESSWIRE / June 17, 2024 / Hemogenyx Pharmaceuticals plc (LSE: HEMO), the clinical stage biopharmaceutical group developing treatments for cancers and viral diseases, is pleased to provide an update on its
The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune (Revised)
Zacks via Yahoo Finance· 5 days agoProthena Corp., AC Immune and Cassava Sciences are also developing therapies for Alzheimer's...